Adenocard Disease Interactions
There are 3 disease interactions with Adenocard (adenosine).
Adenosine (applies to Adenocard) sinus- AV node dysfunction
Major Potential Hazard, High plausibility. Applicable conditions: Heart Block, Sinus Node Dysfunction
The use of adenosine is contraindicated in patients with second- or third-degree AV block, sick sinus syndrome, or symptomatic bradycardia in the absence of a functional artificial pacemaker.
Antiarrhythmics (applies to Adenocard) cardiovascular dysfunction
Major Potential Hazard, Moderate plausibility. Applicable conditions: Hypotension
Antiarrhythmic agents can induce severe hypotension (particularly with IV administration) or induce or worsen congestive heart failure (CHF). Patients with primary cardiomyopathy or inadequately compensated CHF are at increased risk. Antiarrhythmic agents should be administered cautiously and dosage and/or frequency of administration modified in patients with hypotension or adequately compensated CHF. Alternative therapy should be considered unless these conditions are secondary to cardiac arrhythmia.
Adenosine (applies to Adenocard) bronchoconstriction
Moderate Potential Hazard, High plausibility. Applicable conditions: Asthma, Chronic Obstructive Pulmonary Disease
Adenosine induces mast cell degranulation and histamine release. Bronchoconstriction has been reported in patients with asthma during therapy with adenosine. Therapy with adenosine should be administered cautiously in patients with obstructive lung disease not associated with bronchoconstriction (emphysema or bronchitis) and should be avoided in patients with bronchoconstriction or bronchospasm (asthma).
Adenocard drug interactions
There are 218 drug interactions with Adenocard (adenosine).
Adenocard alcohol/food interactions
There are 3 alcohol/food interactions with Adenocard (adenosine).
More about Adenocard (adenosine)
- Adenocard consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: cardiac stressing agents
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.